Another area which adds complexity to maternal vaccine studies is the issue of consent. Depending on regulations, consent may be required from both parents on behalf of the newborn infant.

Three-quarters of infants were exposed to the maternal RSV vaccine or nirsevimab during their first RSV season. Younger mothers and Black mothers were less likely to receive the maternal vaccine.